Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Technology / PCOS Renamed to PMOS Globally
Tech medical renaming

PCOS Renamed to PMOS Globally

Analysis based on 42 articles · First reported May 13, 2026 · Last updated May 14, 2026

Sentiment
50
Attention
4
Articles
42
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The renaming of PCOS to PMOS is expected to improve diagnosis and treatment, potentially increasing demand for related healthcare services, pharmaceuticals, and medical research. This could positively impact companies in the healthcare sector focused on women's health and endocrine disorders.

Healthcare Pharmaceuticals Medical Research
Event Summary

Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS) after a 14-year international initiative led by Helena Teede and involving over 50 patient advocacy and medical organizations, including the Pediatric Endocrine Society. The change, announced alongside research published in The Lancet, aims to address the misleading nature of the old name, which often caused confusion as many patients do not have ovarian cysts. Experts like Melanie Cree and Anuja Dokras emphasize that PMOS is a complex hormonal disorder affecting metabolic and mental health, skin, and the reproductive system, with links to Type 2 diabetes, cardiovascular disease, and infertility. The World Health Organization estimates that up to 70% of affected women are undiagnosed. The transition to PMOS will involve a three-year global education and awareness campaign, with full implementation expected by the 2028 international guideline update. Patient advocates like Lorna Berry and Rachel Morman of Verity PCOS UK believe this change will lead to earlier diagnosis, better treatment, and improved long-term care.

Key Actions
90 Pediatric Endocrine Society announced name change
70 Helena Teede led research
70 Melanie Cree authored article
60 Helena Teede described condition
60 Anuja Dokras contributed to understanding
50 World Health Organization estimated prevalence
50 Verity PCOS UK pushed for recognition
40 Pediatric Endocrine Society stated terminology
Entities Involved
per
Helena Teede
Helena Teede led the 14-year international initiative to rename PCOS to PMOS, aiming to improve diagnosis and care for women worldwide. She is a key figure in this landmark medical change.
Importance 90 Sentiment 20
ngo
Pediatric Endocrine Society
The Pediatric Endocrine Society was involved in the 14-year international process to rename PCOS to PMOS, supporting the change to a more accurate and comprehensive name.
Importance 80 Sentiment 10
per
Melanie Cree
Melanie Cree is one of the authors of The Lancet article announcing the name change and a pediatric endocrinology expert, advocating for the new terminology to enable better care.
Importance 70 Sentiment 20
per
Terhi Piltonen
Terhi Piltonen, president of the International Androgen Excess and Polycystic Ovary Syndrome Society, emphasized the importance of cultural considerations in the renaming process to avoid stigma.
Importance 60 Sentiment 10
per
Anuja Dokras
Anuja Dokras, senior author on The Lancet paper and director of the Penn Polycystic Ovary Syndrome Center, highlighted that the previous name obscured the condition's cardiometabolic and psychological aspects.
Importance 60 Sentiment 10
ngo
International Androgen Excess and Polycystic Ovary Syndrome Society
The International Androgen Excess and Polycystic Ovary Syndrome Society, through its president Terhi Piltonen and executive director Anuja Dokras, was a key participant in the 14-year collaboration to rename PCOS to PMOS.
Importance 60 Sentiment 10
cnt
India
India is experiencing a sharp rise in PMOS diagnoses, especially among urban adolescents and young women, making the name change particularly important for improving awareness and management.
Importance 60 Sentiment 0
ngo
World Health Organization
The World Health Organization estimates the prevalence of PMOS, highlighting the global impact and the need for improved diagnosis and care.
Importance 50 Sentiment 0
ngo
Verity PCOS UK
Verity PCOS UK, a UK PCOS charity, contributed to the renaming process, with its chair Rachel Morman stating the new name accurately reflects the condition's metabolic dimension.
Importance 50 Sentiment 10
per
Thais Aliabadi
Thais Aliabadi, an OBGYN and cofounder of Ovii, supports the new name PMOS as it better reflects the whole-body nature of the condition.
Importance 50 Sentiment 20
per
Rohan Palshetkar
Rohan Palshetkar, an IVF and Fertility Specialist at Bloom IVF, explained that PCOS was an incomplete name and the new terminology will reduce fear and stigma.
Importance 50 Sentiment 20
per
Arun Mukka
Arun Mukka, a Senior Consultant Endocrinologist at Yashoda Hospitals, highlighted that PMOS is a broader metabolic and hormonal condition, not just an ovarian disorder.
Importance 50 Sentiment 20
per
Muskaan Chhabra
Muskaan Chhabra, a Fertility Specialist at Birla Fertility & IVF, believes the name change will broaden understanding beyond fertility concerns alone, especially for women in India.
Importance 50 Sentiment 20
per
M. V. Jyothsna
M. V. Jyothsna, a Consultant Obstetrician and Gynaecologist at Yashoda Hospitals, stated that the new terminology may improve awareness about long-term risks associated with the condition.
Importance 50 Sentiment 20
per
Sarah Hutto
Sarah Hutto, from the University of Minnesota Medical School, provided insights into PMOS's association with metabolic syndrome and increased risks of Type 2 diabetes, heart disease, and stroke.
Importance 40 Sentiment 10
+ 8 more entities View on Dashboard
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.